HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Armitage, J. M. Articles by Griffith, B. P. Search for Related Content PubMed PubMed Citation Articles by Armitage, J. M. Articles by Griffith, B. P.

The Journal of Thoracic and Cardiovascular Surgery, Vol 105, 337-345, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Pediatric lung transplantation. The years 1985 to 1992 and the clinical trial of FK 506

JM Armitage, FJ Fricker, G Kurland, RL Hardesty, M Michaels, S Morita, TE Starzl, SA Yousem, R Jaffe and BP Griffith
Department of Surgery, University of Pittsburgh School of Medicine, PA 15213.

The application of lung transplantation to the pediatric population was a natural extension of the success realized in our adult transplantation program, which began in 1982. Twenty pediatric patients (age range 3 to 18 years) have had heart-lung (n = 11), double lung (n = 8), and single lung (n = 1) transplantation procedures. The causes of end-stage lung disease were primary pulmonary hypertension (n = 7), congenital heart disease (n = 5), cystic fibrosis (n = 4), pulmonary arteriovenous malformation (n = 2), graft-versus-host disease (n = 1), and desquamative interstitial pneumonitis (n = 1). Four (20%) patients had thoracic surgical procedures before the transplantation operation. The survival was 80% at a mean follow-up of 2 years. Immunosuppressive drugs included cyclosporine (n = 9) or FK 506 (n = 11) based therapy with azathioprine and steroids. Children were followed up by means of spirometry, transbronchial biopsy, and primed lymphocyte testing of bronchoalveolar lavage fluid. The mean number of treated episodes of rejection was 1.4 at 30 days, 0.5 at 30 to 90 days, and 1.4 at more than 90 days, and the first treated rejection episode occurred on average 28 days after the operation. Obliterative bronchiolitis developed in four (25%) of 16 patients surviving more than 100 days. Results of pulmonary function tests have remained good in almost all recipients. The greatest infectious risk was that of cytomegalovirus: one death and one case of pneumonia. Posttransplantation lymphoproliferative disease was diagnosed in two (12.5%) patients; both recovered. The most common complications were hypertension (25%) and postoperative bleeding (15%). Early results indicate that lung transplantation is a most promising therapy for children with severe vascular and parenchymal lung disease.

This article has been cited by other articles:

				H. Reichenspurner, R. E. Girgis, R. C. Robbins, J. V. Conte, R. V. Nair, V. Valentine, G. J. Berry, R. E. Morris, J. Theodore, and B. A. Reitz Obliterative Bronchiolitis After Lung and Heart-Lung Transplantation Ann. Thorac. Surg., December 1, 1995; 60(6): 1845 - 1853. [Abstract] [Full Text]

				J. A. Fulton, D. M. Orenstein, A. N. Koehler, and G. Kurland Nutrition in the Pediatric Double Lung Transplant Patient With Cystic Fibrosis Nutr Clin Pract, April 1, 1995; 10(2): 67 - 72. [Abstract] [PDF]

				J. M. Armitage, G. Kurland, M. Michaels, L. A. Cipriani, B. P. Griffith, and F. J. Fricker Critical issues in pediatric lung transplantation J. Thorac. Cardiovasc. Surg., January 1, 1995; 109(1): 60 - 65. [Abstract] [Full Text]

				K. Bando, J. M. Armitage, I. L. Paradis, R. J. Keenan, R. L. Hardesty, H. Konishi, K. Komatsu, K. L. Stein, A. N. Shah, H. T. Bahnson, et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1056 - 1065. [Abstract] [Full Text]